NEPH
HEALTHCARENephros Inc
AI Insight
What's Moving NEPH Today?
No stock-specific AI insight has been generated for NEPH yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.66$6.42
$3.30
Fundamentals
Market Cap$35M
P/E Ratio46.6
EPS$0.07
Dividend Yield—
Dividend / Share—
ROE7.8%
Profit Margin4.1%
Debt / Equity—
Trading
Volume3K
Avg Volume (10D)—
Shares Outstanding10.9M
NEPH News
20 articles- Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”Yahoo Finance·Jun 18, 2026
- Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in WaterYahoo Finance·Jun 16, 2026
- US$7.00 - That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These ResultsYahoo Finance·May 11, 2026
- Nephros, Inc. Q1 2026 Earnings Call SummaryMoby·May 8, 2026
- Nephros Announces Financial Results for Quarter Ended March 31, 2026Yahoo Finance·May 7, 2026
- Nephros Schedules First Quarter 2026 Financial Results Conference CallYahoo Finance·Apr 30, 2026
- 3 Promising Penny Stocks With Market Caps Under $200MYahoo Finance·Apr 30, 2026
- Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional LeadershipYahoo Finance·Apr 16, 2026
- Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning ExpertiseGlobeNewswire Inc.·Apr 1, 2026
- Nephros Inc (NEPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Margin PressuresYahoo Finance·Mar 14, 2026
- Nephros (NEPH) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 13, 2026
- Nephros, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 13, 2026
- Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial ResultsYahoo Finance·Mar 12, 2026
- Nephros Schedules Fourth Quarter 2025 Financial Results Conference CallYahoo Finance·Mar 5, 2026
- Promising Penny Stocks To Consider In February 2026Yahoo Finance·Feb 19, 2026
- Spotlight On Silence Therapeutics And 2 Other Promising Penny StocksYahoo Finance·Feb 19, 2026
- Aureus Greenway Holdings And 2 Other Promising Penny Stocks To WatchYahoo Finance·Feb 18, 2026
- Gaia Leads The Charge With 2 Other Promising Penny StocksYahoo Finance·Feb 17, 2026
- Promising Penny Stocks To Watch In February 2026Yahoo Finance·Feb 16, 2026
- Spotlight On February 2026's Promising Penny StocksYahoo Finance·Feb 13, 2026
All 20 articles loaded
Price Data
Open$3.32
Previous Close$3.26
Day High$3.33
Day Low$3.17
52 Week High$6.42
52 Week Low$2.66
52-Week Range
$2.66$6.42
$3.30
Fundamentals
Market Cap$35M
P/E Ratio46.6
EPS$0.07
Dividend Yield—
Dividend / Share—
ROE7.8%
Profit Margin4.1%
Debt / Equity—
Trading
Volume3K
Avg Volume (10D)—
Shares Outstanding10.9M
About Nephros Inc
Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—